Artisan Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $866M | Sell |
2,411,792
-246,101
| -9% | -$75.2M | 1.37% | 20 |
|
|
2026
Q1 | $666M | Sell |
2,657,893
-192,508
| -7% | -$47.9M | 1.07% | 25 |
|
|
2025
Q4 | $784M | Buy |
2,850,401
+79,481
| +3% | +$21.7M | 1.17% | 19 |
|
|
2025
Q3 | $727M | Buy |
2,770,920
+503,601
| +22% | +$122M | 1.03% | 25 |
|
|
2025
Q2 | $496M | Buy |
2,267,319
+71,836
| +3% | +$15.4M | 0.73% | 37 |
|
|
2025
Q1 | $492M | Sell |
2,195,483
-915,420
| -29% | -$252M | 0.79% | 34 |
|
|
2024
Q4 | $1.02B | Buy |
3,110,903
+44,376
| +1% | +$14M | 1.53% | 14 |
|
|
2024
Q3 | $920M | Buy |
3,066,527
+574,635
| +23% | +$176M | 1.37% | 19 |
|
|
2024
Q2 | $821M | Buy |
2,491,892
+425,355
| +21% | +$150M | 1.23% | 21 |
|
|
2024
Q1 | $818M | Buy |
2,066,537
+105,474
| +5% | +$39M | 1.18% | 25 |
|
|
2023
Q4 | $691M | Buy |
1,961,063
+369,792
| +23% | +$131M | 1.06% | 25 |
|
|
2023
Q3 | $597M | Buy |
1,591,271
+578,796
| +57% | +$224M | 1.01% | 26 |
|
|
2023
Q2 | $387M | Sell |
1,012,475
-152,234
| -13% | -$54.4M | 0.62% | 48 |
|
|
2023
Q1 | $404M | Buy |
1,164,709
+103,905
| +10% | +$30.4M | 0.66% | 48 |
|
|
2022
Q4 | $250M | Buy |
1,060,804
+145,065
| +16% | +$34.4M | 0.44% | 63 |
|
|
2022
Q3 | $225M | Buy |
915,739
+62,491
| +7% | +$19M | 0.4% | 71 |
|
|
2022
Q2 | $258M | Buy |
853,248
+308,549
| +57% | +$100M | 0.44% | 65 |
|
|
2022
Q1 | $224M | Sell |
544,699
-218,495
| -29% | -$85.5M | 0.3% | 96 |
|
|
2021
Q4 | $358M | Sell |
763,194
-36,174
| -5% | -$15.6M | 0.42% | 75 |
|
|
2021
Q3 | $339M | Sell |
799,368
-191,826
| -19% | -$80.9M | 0.41% | 73 |
|
|
2021
Q2 | $356M | Sell |
991,194
-259,005
| -21% | -$85.6M | 0.42% | 70 |
|
|
2021
Q1 | $352M | Sell |
1,250,199
-50,836
| -4% | -$14.5M | 0.45% | 66 |
|
|
2020
Q4 | $369M | Sell |
1,301,035
-56,760
| -4% | -$15.9M | 0.45% | 75 |
|
|
2020
Q3 | $373M | Buy |
1,357,795
+806
| +0.1% | +$213K | 0.53% | 65 |
|
|
2020
Q2 | $308M | Buy |
1,356,989
+156,444
| +13% | +$30.7M | 0.49% | 70 |
|
|
2020
Q1 | $183M | Buy |
1,200,545
+99,512
| +9% | +$15.3M | 0.39% | 71 |
|
|
2019
Q4 | $166M | Buy |
1,101,033
+25,769
| +2% | +$3.75M | 0.29% | 86 |
|
|
2019
Q3 | $152M | Sell |
1,075,264
-9,560
| -0.9% | -$1.32M | 0.29% | 82 |
|
|
2019
Q2 | $136M | Sell |
1,084,824
-26,641
| -2% | -$3.14M | 0.25% | 88 |
|
|
2019
Q1 | $122M | Buy |
1,111,465
+5,052
| +0.5% | +$525K | 0.24% | 89 |
|
|
2018
Q4 | $108M | Sell |
1,106,413
-8,836
| -0.8% | -$959K | 0.24% | 93 |
|
|
2018
Q3 | $138M | Sell |
1,115,249
-58,032
| -5% | -$6.51M | 0.26% | 102 |
|
|
2018
Q2 | $116M | Sell |
1,173,281
-72,584
| -6% | -$6.68M | 0.23% | 118 |
|
|
2018
Q1 | $110M | Buy |
1,245,865
+243,421
| +24% | +$22.8M | 0.22% | 121 |
|
|
2017
Q4 | $98.9M | Buy |
1,002,444
+160,360
| +19% | +$15.7M | 0.19% | 128 |
|
|
2017
Q3 | $81.1M | Buy |
+842,084
| New | +$76.2M | 0.15% | 147 |
|
Other funds holding WST
GIM
Artisan Partners's WST Position: Q2 2026 in Review
Artisan Partners reduced its West Pharmaceutical (WST) stake by 9.3% in Q2 2026, selling an estimated $75.2M and leaving 2,411,792 shares worth $866M. The position accounts for 1.37% of the portfolio, ranked #20.
Artisan Partners first reported a position in WST in Q3 2017 and has held it in 36 quarters since. The position peaked at $1.02B in Q4 2024. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- Artisan Partners held 2,411,792 shares of West Pharmaceutical worth $866M as of Q2 2026.
- Artisan Partners sold 246,101 West Pharmaceutical shares in Q2 2026, an estimated $75.2M.
- West Pharmaceutical made up 1.37% of Artisan Partners's portfolio in Q2 2026, its #20 holding.
- Artisan Partners first reported a position in West Pharmaceutical in Q3 2017 and has held it in 36 quarters since.
- Artisan Partners's West Pharmaceutical position peaked at $1.02B in Q4 2024.
- 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on Artisan Partners's 13F filing for Q2 2026, filed 13 Aug 2026.